|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Acer Therapeutics (NASDAQ: ACER) through any online brokerage.
There are no as such competitors for Acer Therapeutics.
The latest price target for Acer Therapeutics (NASDAQ: ACER) was reported by Needham on 2019-06-25. The analyst firm set a price target for 0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Acer Therapeutics (NASDAQ: ACER) is $2.65 last updated Tue Apr 20 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Acer Therapeutics.
There is no upcoming split for Acer Therapeutics.